|
ATCC
mcf 7 Mcf 7, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/htb+22/MCF7/pmc08513164-35-1-19 Average 99 stars, based on 1 article reviews
mcf 7 - by Bioz Stars,
2026-10
99/100 stars
|
Buy from Supplier |
|
LGC Standards
htb-22 Htb 22, supplied by LGC Standards, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/htb+22/htb-22/custom%40htb-22%4032560271 Average 99 stars, based on 1 article reviews
htb-22 - by Bioz Stars,
2026-10
99/100 stars
|
Buy from Supplier |
|
ATCC
mcf7 human mammary adenocarcinoma ![]() Mcf7 Human Mammary Adenocarcinoma, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/htb+22/MCF7%3B+Breast+Adenocarcinoma%3B+Human/10__1158_slash_1535___7163__mct___10___0568-46-0-4 Average 99 stars, based on 1 article reviews
mcf7 human mammary adenocarcinoma - by Bioz Stars,
2026-10
99/100 stars
|
Buy from Supplier |
|
ATCC
mcf7 luc2 ![]() Mcf7 Luc2, supplied by ATCC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/htb+22/MCF7-Luc2/pm32764667-275-2-20 Average 90 stars, based on 1 article reviews
mcf7 luc2 - by Bioz Stars,
2026-10
90/100 stars
|
Buy from Supplier |
|
ATCC
caki-1 ![]() Caki 1, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/htb+22/Caki-1/custom%40htb-46%4040330887 Average 97 stars, based on 1 article reviews
caki-1 - by Bioz Stars,
2026-10
97/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Molecular Cancer Therapeutics
Article Title: Silencing of Tubulin Binding Cofactor C Modifies Microtubule Dynamics and Cell Cycle Distribution and Enhances Sensitivity to Gemcitabine in Breast Cancer Cells
doi: 10.1158/1535-7163.mct-10-0568
Figure Lengend Snippet: Figure 1. Expression levels of different proteins in MCF7 cells with low TBCC levels. A, representative blots corresponding to TBCC, a-tubulin, b-tubulin, bIII-tubulin, TBCD, Arl2, and b-actin in MC-1, MC-2, MC-3, MP6.1, MP6.2, and MP6.3 cells. B, representative blots corresponding to a-tubulin and b-tubulin in NPT heterodimers, PT heterodimers, microtubule heterodimers, and total pool of tubulins in MC-1 and MP6.1 cells.
Article Snippet:
Techniques: Expressing
Journal: Molecular Cancer Therapeutics
Article Title: Silencing of Tubulin Binding Cofactor C Modifies Microtubule Dynamics and Cell Cycle Distribution and Enhances Sensitivity to Gemcitabine in Breast Cancer Cells
doi: 10.1158/1535-7163.mct-10-0568
Figure Lengend Snippet: Figure 4. Cell cycle distribution and expression level of related proteins. A, percentages of cells in the S-phase and G2-M phase of the cell cycle. MC and MP6 represent the average value of 3 clones of MC or MP6, respectively. MP6.1 þ siRNA SCR, and TBCC correspond to MP6.1 cells transfected with siRNA scrambled and siRNA-targeting TBCC, respectively. Values differ significantly at P < 0.05 (*). Bars represent SD. B, representative blots showing TBCC content in MCF7 cells 48 hours after double-transient transfection with siRNA-targeting TBCC and scrambled siRNA. C, representative blots corresponding to the expression levels of CDK1, cyclin B, CDK2, cyclin E, p21, and p53 at basal levels and after 24 hours exposure to gemcitabine (1 nmol/L) in MC-1 and MP6.1 cells. D, quantification of the expression levels (ratio of protein versus b-actin) of CDK1, cyclin B, CDK2, cyclin E, p21, and p53 in TBCC models.
Article Snippet:
Techniques: Expressing, Clone Assay, Transfection